ICU sedation, delirium & recovery

Effect of Tele-ICU on Clinical Outcomes of Critically Ill Patients: The TELESCOPE Randomized Clinical Trial

JAMAPublished Randomised controlled trial

Primary result · ICU LOSResult — go to the resultPercentage change 8.2% 95% CI −5.4% to 23.8%

Authors' conclusion

Daily multidisciplinary rounds conducted by a board-certified intensivist through telemedicine did not reduce ICU LOS in critically ill adult patients.

Study context

Population
Consecutive adults (≥18 years) admitted to 30 general intensive care units (ICUs) in Brazil without routine intensivist-led daily multidisciplinary rounds1,794 baseline, 15,230 intervention period
Participants
17,024 adults
Comparison
Tele-critical care vs usual care
Primary endpoint
ICU length of stay (LOS) at the patient level
Methodological detailsparallel cluster randomised, baseline period, 30 general ICUs, Median (IQR) time under intervention 20 (16-21) months, Enrolment June 1, 2019 to April 7, 2021; last follow-up July 6, 2021
  • Parallel cluster randomised
  • Baseline period
  • 30 general ICUs
  • Median (IQR) time under intervention 20 (16-21) months
  • Enrolment June 1, 2019 to April 7, 2021; last follow-up July 6, 2021

Primary result

ICU LOS

Percentage change

8.2%

95% CI −5.4% to 23.8%

P = 0.24

By group

Tele-critical care vs Usual care
percentage change 8.2% (95% CI −5.4% to 23.8%); P = 0.24

As reported in the abstract

Secondary outcomes

Sensitivity analyses and prespecified subgroups (subgroup)

Results similar

Other secondary and exploratory outcomes (incl. in-hospital mortality, ventilator-free days at 28 days, infections)

No statistically significant differences

Original publication

Effect of Tele-ICU on Clinical Outcomes of Critically Ill Patients: The TELESCOPE Randomized Clinical Trial. JAMA. Published 3 December 2024. doi:10.1001/jama.2024.20651

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.